Marinus Pharma to explore options as rare disease drug fails trial

Marinus Pharmaceuticals

24/10/2024 13:09

Oct 24 (Reuters) - Marinus Pharmaceuticals  MRNS.O  said
on Thursday that it is exploring strategic alternatives after
its drug for treating seizures related to a rare brain disease
failed to meet the main goal in a late-stage study. 

 (Reporting by Sruthi Narasimha Chari in Bengaluru; Editing by
Abinaya Vijayaraghavan)
 ((SruthiNarasimha.Chari@thomsonreuters.com;))